Aytu BioPharma, Inc.
AYTUDrug Manufacturers - Specialty & Generic
$1.93−2.53%As of Oct 30vs prior close
- Market cap
- $21M
- P/E (TTM)
- –
- From 52W high
- −33.45%
- EPS (LTM)
- -$1.16
- Revenue (LTM)
- $57.6M
- Net margin
- -24.76%
Nomior Score
40
Patient ValueBottom 29% of the scored universe
Growth57
Quality28
Value68
Momentum35
Resilience35
Growth
+37.76%revenue a year over 9 fiscal years
YE17 $3.2MLTM $57.6M
Connections
Revenue to profitQ4 YE26
The operating loss was 5% of revenue, narrower by 46 pts on a year.
Who owns it
1fund